Pircetam 333.3 mg/ml

Oral solution

Nootropil is indicated in adult patients suffering from myoclonus of cortical origin,
irrespective of aetiology, and should be used in combination with other anti-myoclonic
therapies.

Posology
The daily dosage should begin at 7.2 g increasing by 4.8 g every three to four days up to
a maximum of 24 g, divided in two or three doses. Treatment with other anti-myoclonic
medicinal products should be maintained at the same dosage. Depending on the clinical
benefit obtained, the dosage of other such medicinal products should be reduced, if
possible.
Once started, treatment with piracetam should be continued for as long as the original
cerebral disease persists. In patients with an acute episode, spontaneous evolution may
occur over time and an attempt should be made every 6 months to decrease or
discontinue the medicinal treatment. This should be done by reducing the dose of
piracetam by 1.2 g every two days (every three or four days in the case of a Lance and
Adams syndrome, in order to prevent the possibility of sudden relapse or withdrawal
seizures).